AprilBio Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-9,728	20,005	-14,130	-8,959	-52,713
Depreciation & Amortization	689.55	706.33	674.42	593.44	487.25
Loss (Gain) From Sale of Assets	-	0	25.87	0.01	-
Loss (Gain) From Sale of Investments	658.95	-	-	-	-
Stock-Based Compensation	1,136	2,127	959.84	378.87	523.33
Other Operating Activities	4,054	-637.92	3,604	-1,073	57,119
Change in Accounts Receivable	-	-	-	4,292	-4,276
Change in Income Taxes	-181.15	94.9	-264.71	-159.89	-15.57
Change in Other Net Operating Assets	28.29	-335.54	-928.88	-1,776	2,127
Operating Cash Flow	-3,342	21,960	-10,059	-6,704	3,252
Capital Expenditures	-287.84	-445.29	-511.97	-89.59	-705.82
Investment in Securities	5,893	-22,345	-6,500	-31,500	-23,000
Other Investing Activities	0.11	-6.72	-41.77	-52.13	-93.69
Investing Cash Flow	5,605	-22,797	-7,054	-31,642	-23,800
Long-Term Debt Issued	-	-	14,848	-	-
Long-Term Debt Repaid	-362.24	-329.98	-291.45	-248.24	-161.81
Net Debt Issued (Repaid)	-362.24	-329.98	14,556	-248.24	-161.81
Issuance of Common Stock	1,848	1,098	1,755	20,577	24,955
Other Financing Activities	-10.34	-3,281	-0	-0	-0
Financing Cash Flow	1,475	-2,513	16,312	20,328	34,793
Foreign Exchange Rate Adjustments	-12.07	110.51	103.16	924.37	-
Miscellaneous Cash Flow Adjustments	-0	-	-	0	-
Net Cash Flow	3,726	-3,240	-697.32	-17,093	14,245
Free Cash Flow	-3,630	21,514	-10,571	-6,794	2,546
Free Cash Flow Margin	-167.14%	78.19%	-	-3396.76%	10.88%
Free Cash Flow Per Share	-160.09	981.88	-494.99	-347.29	305.34
Levered Free Cash Flow	-8,389	2,492	4,066	-4,137	-18,335
Unlevered Free Cash Flow	-8,002	3,380	4,648	-4,119	-17,014
Change in Working Capital	-152.86	-240.64	-1,194	2,356	-2,164

Source: S&P Global Market Intelligence. Standard template. Financial Sources.